Strategic Design of Conquering Hypoxia in Tumor for Advanced Photodynamic Therapy
Advanced Healthcare Materials · 2023-09 · 12 (24)
DOI: 10.1002/adhm.202300530 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 10.05.2023. Verfasst von Cheng Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Optoelectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory of Photonics Technolo…. Hauptthemen laut MEDLINE: Photochemotherapy, Neoplasms. Die Arbeit wurde bisher 147-mal zitiert (Crossref) und nennt 187 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
Photodynamic therapy (PDT), with its advantages of high targeting, minimally invasive, and low toxicity side effects, has been widely used in the clinical therapy of various tumors, especially superficial tumors. However, the tumor microenvironment (TME) presents hypoxia due to the low oxygen (O 2 ) supply caused by abnormal vascularization in neoplastic tissues and high O 2 consumption induced by the rapid proliferation of tumor cells. The efficacy of oxygen‐consumping PDT can be hampered by a hypoxic TME. To address this problem, researchers have been developing advanced nanoplatforms and strategies to enhance the therapeutic effect of PDT in tumor treatment. This review summarizes recent advanced PDT therapeutic strategies to against the hypoxic TME, thus enhancing PDT efficacy, including increasing O 2 content in TME through delivering O 2 to the tumors and in situ generations of O 2 ; decreasing the O 2 consumption during PDT by design of type I photosensitizers. Moreover, recent synergistically combined therapy of PDT and other therapeutic methods such as chemotherapy, photothermal therapy, immunotherapy, and gas therapy is accounted for by addressing the challenging problems of mono PDT in hypoxic environments, including tumor resistance, proliferation, and metastasis. Finally, perspectives of the opportunities and challenges of PDT in future clinical research and translations are provided.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Optoelectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory of Photonics Technology, Strait Institute of Flexible Electronics (SIFE Future Technologies…
- Strait Laboratory of Flexible Electronics (SLoFE), Fuzhou, 350117, P. R. China.
- Jiangxi Key Laboratory of Nanobiomaterials, School of Materials Science and Engineering, East China Jiaotong University, Nanchang, 330013, P. R. China.
- Department of Pathology, Shengli Clinical Medical College, Fujian Medical University, Fuzhou, 350001, P. R. China.
- Frontiers Science Center for Flexible Electronics (FSCFE), MIIT Key Laboratory of Flexible Electronics (KLoFE) Northwestern Polytechnical University Xi'an, Xi'an, 710072, P. R. China.
ORCID-Profile: Zhen Yang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province
Zitieren
APA
Zhang, C., Hu, X., Jin, L., Lin, L., Lin, H., Yang, Z., & Huang, W. (2023). Strategic Design of Conquering Hypoxia in Tumor for Advanced Photodynamic Therapy. Advanced Healthcare Materials, 12(24). https://doi.org/10.1002/adhm.202300530
Vancouver
Zhang C, Hu X, Jin L, Lin L, Lin H, Yang Z, et al. Strategic Design of Conquering Hypoxia in Tumor for Advanced Photodynamic Therapy. Advanced Healthcare Materials. 2023;12(24). doi:10.1002/adhm.202300530
BibTeX
@article{Zhang2023,
author = {Zhang, Cheng and Hu, Xiaoming and Jin, Long and Lin, Lisheng and Lin, Hongxin and Yang, Zhen and Huang, Wei},
title = {Strategic Design of Conquering Hypoxia in Tumor for Advanced Photodynamic Therapy},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {24},
doi = {10.1002/adhm.202300530}
}
EUVIMED